FTC, Energized By Androgel, Presses For Patent Settlement Ban
This article was originally published in The Pink Sheet Daily
Executive Summary
In the swirling alliances of the health care reform debate, a press conference by FTC and House Democrats features a consumer who feels he was harmed by the deal between Solvay and generic firms.